发明名称 HETEROCYCLIC COMPOUND AND USE THEREFOR
摘要 The present invention provides a compound having cholinergic muscarinic M1 receptor positive allosteric modulator activity, that is useful as a drug for preventing or treating Alzheimer's disease, schizophrenia, pain, sleep disorders, and the like. The present invention pertains to a compound expressed by formula (I) or a salt thereof. (In the formula, R1 represents an optionally substituted amino group, or an optionally substituted cyclic amino group; R2 and R3 each independently represent a hydrogen atom or a substitution group; X represents -CH= or -N=; and ring A represents an optionally substituted 5 through 10 membered ring.)
申请公布号 WO2013129622(A1) 申请公布日期 2013.09.06
申请号 WO2013JP55566 申请日期 2013.02.28
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 SAKAMOTO, HIROKI;SUGIMOTO, TAKAHIRO
分类号 C07D215/56;A61K31/47;A61K31/4709;A61K31/502;A61K31/5377;A61P25/04;A61P25/18;A61P25/20;A61P25/28;A61P43/00;C07D237/28;C07D401/10;C07D401/12;C07D405/12 主分类号 C07D215/56
代理机构 代理人
主权项
地址